# A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

> **NCT00312026** · PHASE4 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 75 (—)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** efalizumab

## Key facts

- **NCT ID:** NCT00312026
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03-30
- **Primary completion:** 2006-11-28
- **Final completion:** 2006-11-28
- **Target enrollment:** 75 (—)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312026, "A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00312026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*